Cellectar Appoints Jim Caruso CEO

(RTTNews) - Cellectar Biosciences Inc. (CLRB), Tuesday said it appointed James Caruso as president and chief executive officer. Caruso replaces Simon Pedder, who retired due to personal family reasons.

Caruso was also named to Cellectar's Board as a Director.

Caruso most recently served as executive vice president, chief operating officer of HIP Innovation Technology LLC. He previously held positions as executive vice president, chief commercial officer at Allos Therapeutics, senior V.P., sales and marketing at Bone Care International, as well as a variety of sales and marketing leadership positions at Novartis, Bristol Myers-Squibb and BASF.